Dr. Ignacio Gonzalez Suarez is a Scientist at Philip Morris International (Neuchatel, Switzerland), where he leads the High Content Screening team. He has 15 years of experience applying fluorescence and confocal microscopy to the study of cancer, aging and metabolic diseases and has authored more than 30 publications, including peer-reviewed manuscripts and book chapters.
Dr. Gonzalez Suarez obtained a degree in Biochemistry from the University of Oviedo (Asturias, Spain) in 1999 and a Ph.D. in Molecular and Cell Biology from the same university in 2006. His research included the use of in vitro and ex vivo models to investigate mechanisms of metal-induced toxicity in the context of chronic kidney disease.
In 2007, he joined the Department of Radiation Oncology, Washington University School of Medicine (St. Louis, USA) as a postdoctoral researcher and later as a research fellow of the American Heart Association. He used different in vitro and in vivo models of disease to investigate molecular mechanisms driving genomic instability in premature aging and cancer.
Dr. Gonzalez Suarez joined Philip Morris International in 2012.